INTERNATIONAL PATENT: ILDONG PHARMACEUTICAL CO., LTD., 일동제약 주식회사 FILES APPLICATION FOR "PHARMACEUTICAL FORMULATION CONTAINING NINTEDANIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHACRYLIC ACID COPOLYMER"

GENEVA, May 12 -- ILDONG PHARMACEUTICAL CO., LTD. (2, Baumoe-ro 27-gil,Seocho-gu,Seoul 06752), 일동제약 주식회사 (서울특별시서초구바우뫼로27길 2) filed a patent application (PCT/KR2025/017506) for "PHARMACEUTICAL FORMULATION CONTAINING NINTEDANIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHACRYLIC ACID COPOLYMER" on Oct 29, 2025. With publication no. WO/2026/095642, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organizatio...